{"id":"W3037338668","doi":"10.1136/annrheumdis-2019-216863","title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; InflaRx; Vifor Pharma; Ministry of Health, Labour and Welfare; Genentech; University of Oxford; CSL Behring; National Institute for Health and Care Research; University of Utah; Insmed; Vasculitis Clinical Research Consortium; University of Pennsylvania; Kiniksa Pharmaceuticals; Mayo Clinic; Vasculitis Foundation; Medical Research Council; National Center for Research Resources; Versus Arthritis; Celgene; NIHR Cambridge Biomedical Research Centre; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; GlaxoSmithKline; University of Pittsburgh","keywords":"Medicine; Rituximab; Internal medicine; Granulomatosis with polyangiitis; Microscopic polyangiitis; Regimen; Vasculitis; Prednisone; Prospective cohort study; Population; Cohort; Cyclophosphamide; Surgery; Gastroenterology; Disease; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204696,0.0001486985,0.0004223856,0.00006848756,0.00005902951,0.00001594785,0.0001679385,0.00009202442,0.0006416697],"category_scores_gemma":[0.001223859,0.00009565044,0.0003321867,0.0005218561,0.00005338627,0.0000803343,0.00006868534,0.0001740846,0.0001035911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002049165,"about_ca_system_score_gemma":0.0001343464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001119613,"about_ca_topic_score_gemma":0.000004513542,"domain_scores_codex":[0.9986491,0.0001315591,0.0003980737,0.000218842,0.0003712267,0.0002311496],"domain_scores_gemma":[0.9990115,0.00008157026,0.0001126594,0.000361875,0.0001026842,0.0003297775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00652126,0.01831467,0.1546326,0.00242416,0.006325071,0.0007121738,0.03730237,0.0005229348,0.003881282,0.002683023,0.3256008,0.4410797],"study_design_scores_gemma":[0.007823567,0.0006612874,0.975158,0.005239335,0.000228613,0.00001432917,0.0005566329,0.0001600977,0.0022718,0.004260028,0.00331012,0.0003162007],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529253,0.003442088,0.000003084317,0.04219291,0.00007685712,0.0005237724,0.00006775842,0.00004324597,0.00072503],"genre_scores_gemma":[0.9908583,0.001931634,0.00002637061,0.006802676,0.00002502141,0.00005744476,0.00002467399,0.00002170006,0.0002522389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8205254,"threshold_uncertainty_score":0.7025833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0387124180293064,"score_gpt":0.3034553782608066,"score_spread":0.2647429602315002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}